Attached files
| file | filename |
|---|---|
| EX-99.2 - EXHIBIT 99.2 - VANGUARD HEALTH SYSTEMS INC | exhibit99263012.htm |
| EX-99.3 - EXHIBIT 99.3 - VANGUARD HEALTH SYSTEMS INC | exhibit99363012.htm |
| EX-99.1 - EXHIBIT 99.1 - VANGUARD HEALTH SYSTEMS INC | exhibit99163012.htm |
| 8-K - 8-K - VANGUARD HEALTH SYSTEMS INC | a8-kbody063012.htm |
EXHIBIT 99.4
VANGUARD HEALTH SYSTEMS, INC.
Supplementary Financial Information
Normalized Diluted Earnings Per Share
Presentation of Most Directly Comparable GAAP Financial Measure
(Diluted Earnings Per Share) and Reconciliation of Normalized Diluted Earnings Per Share
to Diluted Earnings Per Share
($ presented in millions except per share amounts, unaudited) | Quarter ended | |||
June 30, 2012 | ||||
Income from continuing operations before income taxes | $ | 20.2 | ||
Income tax expense | (1.8 | ) | ||
Income from continuing operations | 18.4 | |||
Loss from discontinued operations, net of taxes | — | |||
Net income | 18.4 | |||
Net loss attributable to non-controlling interests | 0.9 | |||
Net income attributable to Vanguard Health Systems, Inc. stockholders | 19.3 | |||
Diluted weighted average shares outstanding (in thousands) | 79,148 | |||
Diluted earnings per share | $ | 0.24 | ||
Income from continuing operations before income taxes | $ | 20.2 | ||
Income tax expense | (1.8 | ) | ||
Additional tax expense adjustment necessary to reflect a 39% effective tax rate | (6.1 | ) | ||
Income from continuing operations (as normalized) | 12.3 | |||
Loss from discontinued operations, net of taxes | — | |||
Net income (as normalized) | 12.3 | |||
Net loss attributable to non-controlling interests | 0.9 | |||
Net income attributable to Vanguard Health Systems, Inc. stockholders (as normalized) | 13.2 | |||
Diluted weighted average shares outstanding (in thousands) | 79,148 | |||
Normalized diluted earnings per share | $ | 0.16 | ||